This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maron, B. J. Articles by Sherrid, M. V. Search for Related Content PubMed PubMed Citation Articles by Maron, B. J. Articles by Sherrid, M. V.

Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy

Barry J. Maron, MD, FACC^*,*, Kevin P. Carney, BS^*, Harry M. Lever, MD, FACC, Jannet F. Lewis, MD, FACC, Ivan Barac, MD, Susan A. Casey, RN^* and Mark V. Sherrid, MD, FACC

^* Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
Cleveland Clinic Foundation, Cleveland, Ohio, USA
University of Florida Health Sciences Center, Gainesville, Florida, USA
St. Luke’s-Roosevelt Hospital Center, New York, New York, USA

View larger version (37K): [in a new window]   Figure 1 Distribution according to race shown separately for the overall autopsy-based study population of 286 trained competitive athletes who died suddenly from a variety of cardiovascular diseases (left), for those 102 athletes studied at autopsy who died of hypertrophic cardiomyopathy (HCM) (center), and a clinically identified, multicenter hospital-based cohort of 1,986 patients with HCM (right). SCD = sudden cardiac death.

View larger version (47K): [in a new window]   Figure 2 Impact of race on cardiovascular causes of sudden death in the population of 286 competitive athletes, with data shown for those seven structural heart diseases represented by at least 10 deaths. Ao = aortic; ARVC = arrhythmogenic right ventricular cardiomyopathy; CAD = atherosclerotic coronary artery disease; HCM = hypertrophic cardiomyopathy.